Drugs
2006 Public Health Advisories
Update on Magnetic Resonance Imaging (MRI) Contrast Agents Containing Gadolinium and Nephrogenic Fibrosing Dermopathy (12/22/2006)
Life-threatening Brain Infection in Patients with Systemic Lupus Erythematosus After Rituxan (Rituximab) Treatment (12/18/2006)
Methadone Use for Pain Control May Result in Death and Life-Threatening Changes in Breathing and Heart Beat (11/27/2006)
Epoetin alfa (marketed as Procrit, Epogen) Darbepoetin alfa (marketed as Aranesp) (11/16/2006)
Aprotinin Injection (marketed as Trasylol) (9/29/2006)
Consumers Should Not Use Triaminic Vapor Patch (6/20/2006)
Gadolinium-containing Contrast Agents for Magnetic Resonance Imaging (MRI) (6/8/2006)
Angiotensin-Converting Enzyme Inhibitor (ACE inhibitor) Drugs and Pregnancy (6/7/2006)
Diastat AcuDial (3/30/2006)
Sepsis and medical abortion with mifepristone (Mifeprex) (3/17/2006)
Benzocaine Sprays marketed under different names, including Hurricaine, Topex, and Cetacaine (2/10/2006)
Trasylol (aprotinin injection) (2/8/2006)
Ketek (telithromycin) Tables (1/20/2006)
FDA warns of consequences of drug name confusion in U.S. prescriptions filled abroad. FDA News Public Health Advisory (1/11/2006)